Sangamo Biosciences (SGMO) Catches Eye: Stock Soars 38.3% – Tale of the Tape

ZacksSangamo Biosciences Inc. (SGMO) was a big mover last session with shares rising over 38% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $13.25 to $14.38 since Dec 23.

This biopharmaceutical company saw no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s sharp climb is encouraging though, so make sure to keep a close watch on this firm in the near future.

Sangamo Biosciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the BioMed sector include Actelion Ltd. (ALIOF), Affymetrix Inc. (AFFX) and Gentium S.p.A (GENT). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply